Celebrex (celecoxib) : Pharmacia : COX-2 inhibitor

Q&A: NIH Halts Use of COX-2 Inhibitor in Large Cancer Prevention Trial (National Institutes of Health)
Answers to questions regarding the use of celecoxib (Celebrex), a COX-2 inhibitor, in NIH studies, including those investigating celecoxib for the prevention and treatment of lung cancer. Recent reports that COX-2 inhibitors increase the risk of major fatal and non-fatal cardiovascular events have prompted a re-evaluation of ongoing studies. [12/04]

Celebrex (celecoxib) - Recent MEDLINE Abstracts

Celebrex (celecoxib) Clinical Trials (ClinicalTrials.gov)